Question

the nurse has administered anakinra to a client. which assessment finding should the nurse prioritize? abdominal pain pancytopenia constipation retinal changes

Answer 1

When administering anakinra, the nurse should prioritize monitoring for pancytopenia, a serious hematologic effect that can lead to complications such as infection, severe anemia, and hemorrhage.

Step-by-step explanation:

When a nurse administers anakinra, a priority assessment finding to monitor for would be pancytopenia. Anakinra is an interleukin-1 receptor antagonist used to treat rheumatoid arthritis and other inflammatory conditions, and it can cause serious hematologic effects including pancytopenia, which is a reduction in the number of red and white blood cells, as well as platelets. Monitoring for signs of infection, fatigue, and bleeding can detect this potential complication early on. While abdominal pain, constipation, and retinal changes are important to assess for, they are not as directly associated with anakinra as pancytopenia. In the case of a severe adverse reaction such as anakinra-induced pancytopenia, rapid intervention is crucial to prevent serious complications like infections, severe anemia, and hemorrhage.